z-logo
Premium
Repeat liposuction‐curettage treatment of axillary hyperhidrosis is safe and effective
Author(s) -
Bechara F.G.,
Sand M.,
Tomi N.S.,
Altmeyer P.,
Hoffmann K.
Publication year - 2007
Publication title -
british journal of dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.304
H-Index - 179
eISSN - 1365-2133
pISSN - 0007-0963
DOI - 10.1111/j.1365-2133.2007.08092.x
Subject(s) - medicine , liposuction , surgery , curettage , scars , hyperhidrosis , cannula , patient satisfaction
Summary Background  Liposuction‐curettage (LC) is an effective surgical therapy option for axillary hyperhidrosis, with less scarring compared with radical excision of axillary skin. Although this method has proven to be effective, the treatment of nonresponders to minimally invasive surgery has not been previously defined. Whether these patients benefit from a second surgical procedure has not been evaluated so far. Objectives  To investigate efficacy and side‐effects of a second LC with an aggressive rasping cannula in patients with insufficient prior surgery. Methods  Nineteen nonresponders to prior LC (13 female and six male) underwent a second LC with a rasping cannula. Gravimetry was performed before and 8 months after surgery. Side‐effects, patient satisfaction, the surgeons’ intraoperative evaluation and the Vancouver Scar Scale (VSS) before and after surgery were documented. Results  Sweat rates showed a reduction of 69% in 17 (89%) patients. Two patients (11%) did not respond to surgery. Eighty‐four per cent of all patients were completely satisfied or satisfied with postoperative results. No severe side‐effects were observed. The surgeon reported slightly increased difficulties during dissection of dermis from subcutaneous fat in three patients. Assessment of scars showed an excellent aesthetic outcome (mean VSS 0·79 before vs. 1·1 after surgery). Conclusions  LC using an aggressive cannula is an effective therapy option for patients with insufficient response to prior LC surgery, with a low risk of side‐effects.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here